OCUL
Price
$6.95
Change
-$0.34 (-4.66%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.68B
38 days until earnings call
Intraday BUY SELL Signals
WVE
Price
$3.79
Change
-$0.09 (-2.32%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
723.17M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OCUL vs WVE

OCUL vs WVE Comparison Chart in %
View a ticker or compare two or three
VS
OCUL vs. WVE commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and WVE is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
OCUL vs WVE: Fundamental Ratings
OCUL
WVE
OUTLOOK RATING
1..100
6766
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
8390
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (21) in the Biotechnology industry is in the same range as OCUL (35) in the Pharmaceuticals Other industry. This means that WVE’s stock grew similarly to OCUL’s over the last 12 months.

WVE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OCUL (100) in the Pharmaceuticals Other industry. This means that WVE’s stock grew similarly to OCUL’s over the last 12 months.

WVE's SMR Rating (98) in the Biotechnology industry is in the same range as OCUL (98) in the Pharmaceuticals Other industry. This means that WVE’s stock grew similarly to OCUL’s over the last 12 months.

OCUL's Price Growth Rating (83) in the Pharmaceuticals Other industry is in the same range as WVE (90) in the Biotechnology industry. This means that OCUL’s stock grew similarly to WVE’s over the last 12 months.

OCUL's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as WVE (100) in the Biotechnology industry. This means that OCUL’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OCULWVE
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (OCUL: $7.29 vs. WVE: $3.88)
Brand notoriety: OCUL and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 161% vs. WVE: 155%
Market capitalization -- OCUL: $1.68B vs. WVE: $723.17M
OCUL [@Biotechnology] is valued at $1.68B. WVE’s [@Biotechnology] market capitalization is $723.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green while WVE’s FA Score has 1 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 1 green, 4 red.
According to our system of comparison, both OCUL and WVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • OCUL’s TA Score: 5 bullish, 6 bearish.
  • WVE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, WVE is a better buy in the short-term than OCUL.

Price Growth

OCUL (@Biotechnology) experienced а -25.76% price change this week, while WVE (@Biotechnology) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 09, 2026.

WVE is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
OCUL
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRE2.720.11
+4.21%
Cre8 Enterprise Ltd
RGC6.330.11
+1.77%
Regencell Bioscience Holdings Limited
ANNA2.640.01
+0.19%
AleAnna Inc
DOW27.590.05
+0.18%
Dow
TROX3.82-0.13
-3.29%
Tronox Limited

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with AMLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-4.95%
AMLX - OCUL
47%
Loosely correlated
-3.51%
KYMR - OCUL
46%
Loosely correlated
-1.49%
WVE - OCUL
42%
Loosely correlated
+4.86%
NRIX - OCUL
41%
Loosely correlated
-1.56%
MLTX - OCUL
41%
Loosely correlated
-1.97%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with GPCR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+4.86%
GPCR - WVE
64%
Loosely correlated
-7.32%
KYMR - WVE
52%
Loosely correlated
-1.49%
IBIO - WVE
47%
Loosely correlated
-5.93%
FRMM - WVE
44%
Loosely correlated
-0.64%
ELVN - WVE
41%
Loosely correlated
+0.81%
More